Tracey Dexter, EVP and CFO of Seacoast Banking Corp of Florida, filed a Form 4 on November 4, 2026, disclosing a stock option exercise transacted on November 2, 2026.

Key Highlights

  • Transaction: Tracey Dexter exercised 300 stock options (transaction code M) in Common Stock on November 2, 2026, at an exercise price of $31.15 per share.
  • Market price at exercise: According to the filing, the market price on the date of exercise was $34.00.
  • Direct ownership after transaction: The filing reports 46,331 shares of Common Stock directly owned following the reported transaction.
  • Remaining derivative position: 892 Common Stock Rights to Buy remain directly held following the exercise, with an expiration date of April 1, 2028.
  • Additional indirect holdings: The filing discloses separate positions of 3,294, 2,792, and 5,737 shares tied to restricted stock grants, 2,469.901 shares held in Seacoast's Executive Deferred Compensation Plan, and 1,151 shares in the Company's Employee Stock Purchase Plan.
  • Signing authority: The form was signed by Kathy L. Hsu as Power of Attorney for Tracey Dexter on November 4, 2026.

Dexter Tracey's Option Exercise and Beneficial Ownership at Seacoast Banking

According to the Form 4 filed with the SEC on November 4, 2026, Tracey Dexter, identified in the filing as EVP and CFO of Seacoast Banking Corp of Florida (NASDAQ:SBCF), exercised 300 stock options on November 2, 2026, at a conversion or exercise price of $31.15 per share. The filing notes that the market price on the date of exercise was $34.00. The options were granted pursuant to the Company's Amended and Restated 2013 Incentive Plan and were set to vest over three years in one-third increments each anniversary of the date of grant, subject to continued employment.

Following the exercise, the filing reports that Dexter directly holds 46,331 shares of Common Stock. The Form 4 also discloses several additional positions: 3,294 shares representing unvested time-based restricted stock units granted on April 15, 2026, vesting over three years beginning April 15, 2027; 2,792 shares representing an unvested restricted stock award granted on April 1, 2025, vesting over three years beginning April 1, 2026; and 5,737 shares from a restricted stock award granted on April 1, 2024, vesting over three years beginning April 1, 2025, each subject to continued employment.

The filing further discloses 2,469.901 shares held in Seacoast's Executive Deferred Compensation Plan and 1,151 shares in the Company's Employee Stock Purchase Plan. In Table II, the filing reports that 892 Common Stock Rights to Buy remain directly held following the reported transaction, with an expiration date of April 1, 2028, at the same exercise price of $31.15.

What Was Disclosed

The filing discloses a single option exercise of 300 shares by Seacoast Banking Corp of Florida's EVP and CFO, Tracey Dexter, on November 2, 2026, at $31.15 per share, with a reported market price of $34.00, along with the reporting person's full beneficial ownership positions across multiple equity arrangements.